<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">30111577</PMID>
      <DateCompleted>
        <Year>2019</Year>
        <Month>03</Month>
        <Day>15</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2019</Year>
        <Month>08</Month>
        <Day>15</Day>
      </DateRevised>
      <Article PubModel="Electronic-Print">
        <Journal>
          <ISSN IssnType="Electronic">1098-6618</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>31</Volume>
            <Issue>4</Issue>
            <PubDate>
              <Year>2018</Year>
              <Month>Oct</Month>
            </PubDate>
          </JournalIssue>
          <Title>Clinical microbiology reviews</Title>
          <ISOAbbreviation>Clin Microbiol Rev</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Perinatal Streptococcus agalactiae Epidemiology and Surveillance Targets.</ArticleTitle>
        <ELocationID EIdType="pii" ValidYN="Y">e00049-18</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1128/CMR.00049-18</ELocationID>
        <Abstract>
          <AbstractText><i>Streptococcus agalactiae</i>, or group B streptococcus (GBS), is a major neonatal pathogen. Recent data have elucidated the global prevalence of maternal and neonatal colonization, but gaps still remain in the epidemiology of this species. A number of phenotypic and genotypic classifications can be used to identify the diversity of GBS strains, and some are more discriminatory than others. This review explores the main schemes used for GBS epidemiology and further details the targets for epidemiological surveillance. Current screening practices across the world provide a unique opportunity to gain detailed information on maternal colonizing strains and neonatal disease-causing strains, which is vital for monitoring and therapeutics, if sufficient detail can be extracted. Deciphering which isolates are circulating within specific populations and recording targets within invasive strains are crucial steps in monitoring the implementation of therapeutics, such as vaccines, as well as developing novel therapies against prevalent GBS strains. Having a detailed understanding of global GBS epidemiology will prove invaluable for understanding the pathogenesis of this organism and equipping future prevention strategies for success.</AbstractText>
          <CopyrightInformation>Copyright © 2018 American Society for Microbiology.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Furfaro</LastName>
            <ForeName>Lucy L</ForeName>
            <Initials>LL</Initials>
            <Identifier Source="ORCID">0000-0001-7652-0713</Identifier>
            <AffiliationInfo>
              <Affiliation>School of Medicine, Division of Obstetrics and Gynaecology, The University of Western Australia, Crawley, Australia lucy.furfaro@uwa.edu.au.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Chang</LastName>
            <ForeName>Barbara J</ForeName>
            <Initials>BJ</Initials>
            <AffiliationInfo>
              <Affiliation>School of Biomedical Sciences, The Marshall Centre for Infectious Diseases Research and Training, The University of Western Australia, Crawley, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Payne</LastName>
            <ForeName>Matthew S</ForeName>
            <Initials>MS</Initials>
            <AffiliationInfo>
              <Affiliation>School of Medicine, Division of Obstetrics and Gynaecology, The University of Western Australia, Crawley, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2018</Year>
          <Month>08</Month>
          <Day>15</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Clin Microbiol Rev</MedlineTA>
        <NlmUniqueID>8807282</NlmUniqueID>
        <ISSNLinking>0893-8512</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D062665" MajorTopicYN="N">Epidemiological Monitoring</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013290" MajorTopicYN="N">Streptococcal Infections</DescriptorName>
          <QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
          <QualifierName UI="Q000382" MajorTopicYN="Y">microbiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013292" MajorTopicYN="N">Streptococcus agalactiae</DescriptorName>
          <QualifierName UI="Q000145" MajorTopicYN="N">classification</QualifierName>
          <QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="Y">Streptococcus agalactiae</Keyword>
        <Keyword MajorTopicYN="Y">clonal complex</Keyword>
        <Keyword MajorTopicYN="Y">epidemiology</Keyword>
        <Keyword MajorTopicYN="Y">group B streptococcus</Keyword>
        <Keyword MajorTopicYN="Y">immunization</Keyword>
        <Keyword MajorTopicYN="Y">perinatal infections</Keyword>
        <Keyword MajorTopicYN="Y">sequence type</Keyword>
        <Keyword MajorTopicYN="Y">serotype</Keyword>
        <Keyword MajorTopicYN="Y">surveillance</Keyword>
        <Keyword MajorTopicYN="Y">vaccine</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>8</Month>
          <Day>17</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>8</Month>
          <Day>17</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2019</Year>
          <Month>3</Month>
          <Day>16</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">30111577</ArticleId>
        <ArticleId IdType="pmc">PMC6148196</ArticleId>
        <ArticleId IdType="doi">10.1128/CMR.00049-18</ArticleId>
        <ArticleId IdType="pii">31/4/e00049-18</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Lancefield RC.
1933. 
A serological differentiation of human and other groups of hemolytic streptococci. J Exp Med
57:571–595. doi:10.1084/jem.57.4.571.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1084/jem.57.4.571</ArticleId>
            <ArticleId IdType="pmc">PMC2132252</ArticleId>
            <ArticleId IdType="pubmed">19870148</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Heath PT, Schuchat A. 
2007. 
Perinatal group B streptococcal disease. Best Pract Res Clin Obstet Gynaecol
21:411–424. doi:10.1016/j.bpobgyn.2007.01.003.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.bpobgyn.2007.01.003</ArticleId>
            <ArticleId IdType="pubmed">17336588</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Schuchat A.
1998. 
Epidemiology of group B streptococcal disease in the United States: shifting paradigms. Clin Microbiol Rev
11:497–513.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC88893</ArticleId>
            <ArticleId IdType="pubmed">9665980</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fujita H, Nakamura I, Tsukimori A, Sato A, Ohkusu K, Matsumoto T. 
2015. 
Severe infective endocarditis in a healthy adult due to Streptococcus agalactiae. Int J Infect Dis
38:43–45. doi:10.1016/j.ijid.2015.07.009.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ijid.2015.07.009</ArticleId>
            <ArticleId IdType="pubmed">26188131</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li LQ, Cheema S, Goel N. 
2016. 
Group B streptococcal meningitis in a previously healthy man. BMJ Case Rep
2016:bcr2015213999. doi:10.1136/bcr-2015-213999.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/bcr-2015-213999</ArticleId>
            <ArticleId IdType="pmc">PMC4716426</ArticleId>
            <ArticleId IdType="pubmed">26759446</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Oddie S, Embleton ND. 
2002. 
Risk factors for early onset neonatal group B streptococcal sepsis: case-control study. BMJ
325:308. doi:10.1136/bmj.325.7359.308.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/bmj.325.7359.308</ArticleId>
            <ArticleId IdType="pmc">PMC117770</ArticleId>
            <ArticleId IdType="pubmed">12169506</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lin F-YC, Weisman LE, Troendle J, Adams K. 
2003. 
Prematurity is the major risk factor for late-onset group B Streptococcus disease. J Infect Dis
188:267–271. doi:10.1086/376457.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1086/376457</ArticleId>
            <ArticleId IdType="pubmed">12854082</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Berardi A, Rossi C, Guidotti I, Vellani G, Lugli L, Bacchi Reggiani ML, Ferrari F, Facchinetti F, Ferrari F. 
2014. 
Factors associated with intrapartum transmission of group B Streptococcus. Pediatr Infect Dis J
33:1211–1215. doi:10.1097/INF.0000000000000439.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/INF.0000000000000439</ArticleId>
            <ArticleId IdType="pubmed">25037035</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Aber RC, Allen N, Howell JT, Wilkenson HW, Facklam RR. 
1976. 
Nosocomial transmission of group B streptococci. Pediatrics
58:346–353.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">785356</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Verani JR, McGee L, Schrag SJ. 
2010. 
Prevention of perinatal group B streptococcal disease—revised guidelines from CDC, 2010. MMWR Recomm Rep
59:1–36.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21088663</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cagno CK, Pettit JM, Weiss BD. 
2012. 
Prevention of perinatal group B streptococcal disease: updated CDC guideline. Am Fam Physician
86:59–65.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22962913</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rosa-Fraile M, Spellerberg B. 
2017. 
Reliable detection of group B Streptococcus in the clinical laboratory. J Clin Microbiol
55:2590–2598. doi:10.1128/JCM.00582-17.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/JCM.00582-17</ArticleId>
            <ArticleId IdType="pmc">PMC5648696</ArticleId>
            <ArticleId IdType="pubmed">28659318</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Imperi M, Pataracchia M, Alfarone G, Baldassarri L, Orefici G, Creti R. 
2010. 
A multiplex PCR assay for the direct identification of the capsular type (Ia to IX) of Streptococcus agalactiae. J Microbiol Methods
80:212–214. doi:10.1016/j.mimet.2009.11.010.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.mimet.2009.11.010</ArticleId>
            <ArticleId IdType="pubmed">19958797</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Slotved HC, Kong F, Lambertsen L, Sauer S, Gilbert GL. 
2007. 
Serotype IX, a proposed new Streptococcus agalactiae serotype. J Clin Microbiol
45:2929–2936. doi:10.1128/JCM.00117-07.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/JCM.00117-07</ArticleId>
            <ArticleId IdType="pmc">PMC2045254</ArticleId>
            <ArticleId IdType="pubmed">17634306</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Furfaro LL, Chang BJ, Payne MS. 
2017. 
A novel one-step real-time multiplex PCR assay to detect Streptococcus agalactiae presence and serotypes Ia, Ib and III. Diagn Microbiol Infect Dis
89:7–12. doi:10.1016/j.diagmicrobio.2017.06.003.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.diagmicrobio.2017.06.003</ArticleId>
            <ArticleId IdType="pubmed">28669679</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yao K, Poulsen K, Maione D, Rinaudo CD, Baldassarri L, Telford JL, Sorensen UB, Kilian M. 
2013. 
Capsular gene typing of Streptococcus agalactiae compared to serotyping by latex agglutination. J Clin Microbiol
51:503–507. doi:10.1128/JCM.02417-12.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/JCM.02417-12</ArticleId>
            <ArticleId IdType="pmc">PMC3553911</ArticleId>
            <ArticleId IdType="pubmed">23196363</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zeng X, Kong F, Wang H, Darbar A, Gilbert GL. 
2006. 
Simultaneous detection of nine antibiotic resistance-related genes in Streptococcus agalactiae using multiplex PCR and reverse line blot hybridization assay. Antimicrob Agents Chemother
50:204–209. doi:10.1128/AAC.50.1.204-209.2006.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/AAC.50.1.204-209.2006</ArticleId>
            <ArticleId IdType="pmc">PMC1346803</ArticleId>
            <ArticleId IdType="pubmed">16377687</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Eskandarian N, Ismail Z, Neela V, van Belkum A, Desa MN, Amin Nordin S. 
2015. 
Antimicrobial susceptibility profiles, serotype distribution and virulence determinants among invasive, non-invasive and colonizing Streptococcus agalactiae (group B streptococcus) from Malaysian patients. Eur J Clin Microbiol Infect Dis
34:579–584. doi:10.1007/s10096-014-2265-x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s10096-014-2265-x</ArticleId>
            <ArticleId IdType="pmc">PMC4356882</ArticleId>
            <ArticleId IdType="pubmed">25359580</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dutra VG, Alves VM, Olendzki AN, Dias CA, de Bastos AF, Santos GO, de Amorin EL, Sousa MA, Santos R, Ribeiro PC, Fontes CF, Andrey M, Magalhaes K, Araujo AA, Paffadore LF, Marconi C, Murta EF, Fernandes PC Jr, Raddi MS, Marinho PS, Bornia RB, Palmeiro JK, Dalla-Costa LM, Pinto TC, Botelho AC, Teixeira LM, Fracalanzza SE. 
2014. 
Streptococcus agalactiae in Brazil: serotype distribution, virulence determinants and antimicrobial susceptibility. BMC Infect Dis
14:323. doi:10.1186/1471-2334-14-323.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/1471-2334-14-323</ArticleId>
            <ArticleId IdType="pmc">PMC4061772</ArticleId>
            <ArticleId IdType="pubmed">24919844</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Florindo C, Damiao V, Silvestre I, Farinha C, Rodrigues F, Nogueira F, Martins-Pereira F, Castro R, Borrego MJ, Santos-Sanches I. 
2014. 
Epidemiological surveillance of colonising group B Streptococcus epidemiology in the Lisbon and Tagus Valley regions, Portugal (2005 to 2012): emergence of a new epidemic type IV/clonal complex 17 clone. Euro Surveill
19:20825. doi:10.2807/1560-7917.ES2014.19.23.20825.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2807/1560-7917.ES2014.19.23.20825</ArticleId>
            <ArticleId IdType="pubmed">24957747</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tyrrell GJ, Senzilet LD, Spika JS, Kertesz DA, Alagaratnam M, Lovgren M, Talbot JA. 
2000. 
Invasive disease due to group B streptococcal infection in adults: results from a Canadian, population-based, active laboratory surveillance study—1996. Sentinel Health Unit Surveillance System Site Coordinators. J Infect Dis
182:168–173.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10882594</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tsolia M, Psoma M, Gavrili S, Petrochilou V, Michalas S, Legakis N, Karpathios T. 
2003. 
Group B streptococcus colonization of Greek pregnant women and neonates: prevalence, risk factors and serotypes. Clin Microbiol Infect
9:832–838. doi:10.1046/j.1469-0691.2003.00662.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1046/j.1469-0691.2003.00662.x</ArticleId>
            <ArticleId IdType="pubmed">14616704</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Davies HD, Raj S, Adair C, Robinson J, McGeer A. 
2001. 
Population-based active surveillance for neonatal group B streptococcal infections in Alberta, Canada: implications for vaccine formulation. Pediatr Infect Dis J
20:879–884. doi:10.1097/00006454-200109000-00011.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/00006454-200109000-00011</ArticleId>
            <ArticleId IdType="pubmed">11734768</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Russell NJ, Seale AC, O'Driscoll M, O'Sullivan C, Bianchi-Jassir F, Gonzalez-Guarin J, Lawn JE, Baker CJ, Bartlett L, Cutland C, Gravett MG, Heath PT, Le Doare K, Madhi SA, Rubens CE, Schrag S, Sobanjo-ter Meulen A, Vekemans J, Saha SK, Ip M, Asturias E, Gaind R, Kumar P, Anthony B, Madrid L, Bassat Q, Zhu C, Luo M, Nagarjuna D, Majumder S. 
2017. 
Maternal colonization with group B Streptococcus and serotype distribution worldwide: systematic review and meta-analyses. Clin Infect Dis
65:S100–S111. doi:10.1093/cid/cix658.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/cid/cix658</ArticleId>
            <ArticleId IdType="pmc">PMC5848259</ArticleId>
            <ArticleId IdType="pubmed">29117327</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Madrid L, Seale AC, Kohli-Lynch M, Edmond KM, Lawn JE, Heath PT, Madhi SA, Baker CJ, Bartlett L, Cutland C, Gravett MG, Ip M, Le Doare K, Rubens CE, Saha SK, Sobanjo-ter Meulen A, Vekemans J, Schrag S, Agarwal R, da Silva ARA, Bassat Q, Berkley JA, Dangor Z, Dhaded S, Giannoni E, Hammoud M, Kobayahsi M, O'Sullivan C, Sakata H, Sridhar S, Sigaúque B, Tyrrell G, Paul V. 
2017. 
Infant group B streptococcal disease incidence and serotypes worldwide: systematic review and meta-analyses. Clin Infect Dis
65:S160–S172. doi:10.1093/cid/cix656.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/cid/cix656</ArticleId>
            <ArticleId IdType="pmc">PMC5850457</ArticleId>
            <ArticleId IdType="pubmed">29117326</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hall J, Adams NH, Bartlett L, Seale AC, Lamagni T, Bianchi-Jassir F, Lawn JE, Baker CJ, Cutland C, Heath PT, Ip M, Le Doare K, Madhi SA, Rubens CE, Saha SK, Schrag S, Sobanjo-ter Meulen A, Vekemans J, Gravett MG. 
2017. 
Maternal disease with group B Streptococcus and serotype distribution worldwide: systematic review and meta-analyses. Clin Infect Dis
65:S112–S124. doi:10.1093/cid/cix660.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/cid/cix660</ArticleId>
            <ArticleId IdType="pmc">PMC5850000</ArticleId>
            <ArticleId IdType="pubmed">29117328</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Edmond KM, Kortsalioudaki C, Scott S, Schrag SJ, Zaidi AK, Cousens S, Heath PT. 
2012. 
Group B streptococcal disease in infants aged younger than 3 months: systematic review and meta-analysis. Lancet
379:547–556. doi:10.1016/S0140-6736(11)61651-6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0140-6736(11)61651-6</ArticleId>
            <ArticleId IdType="pubmed">22226047</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lin HC, Chen CJ, Chiang KH, Yen TY, Ho CM, Hwang KP, Su BH, Lin HC, Li TC, Lu JJ. 
2016. 
Clonal dissemination of invasive and colonizing clonal complex 1 of serotype VI group B Streptococcus in central Taiwan. J Microbiol Immunol Infect
49:902–909. doi:10.1016/j.jmii.2014.11.002.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jmii.2014.11.002</ArticleId>
            <ArticleId IdType="pubmed">25560254</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Uh Y, Kim HY, Jang IH, Hwang GY, Yoon KJ. 
2005. 
Correlation of serotypes and genotypes of macrolide-resistant Streptococcus agalactiae. Yonsei Med J
46:480–483. doi:10.3349/ymj.2005.46.4.480.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3349/ymj.2005.46.4.480</ArticleId>
            <ArticleId IdType="pmc">PMC2815831</ArticleId>
            <ArticleId IdType="pubmed">16127771</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Turner C, Turner P, Po L, Maner N, De Zoysa A, Afshar B, Efstratiou A, Heath PT, Nosten F. 
2012. 
Group B streptococcal carriage, serotype distribution and antibiotic susceptibilities in pregnant women at the time of delivery in a refugee population on the Thai-Myanmar border. BMC Infect Dis
12:34. doi:10.1186/1471-2334-12-34.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/1471-2334-12-34</ArticleId>
            <ArticleId IdType="pmc">PMC3315410</ArticleId>
            <ArticleId IdType="pubmed">22316399</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lopez Y, Parra E, Cepas V, Sanfeliu I, Juncosa T, Andreu A, Xercavins M, Perez J, Sanz S, Vergara A, Bosch J, Soto SM. 
2017. 
Serotype, virulence profile, antimicrobial resistance and macrolide-resistance determinants in Streptococcus agalactiae isolates in pregnant women and neonates in Catalonia, Spain. Enferm Infecc Microbiol Clin
2017:S0213-005X(17)30226-4. doi:10.1016/j.eimc.2017.08.006.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.eimc.2017.08.006</ArticleId>
            <ArticleId IdType="pubmed">29029763</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Elikwu CJ, Oduyebo O, Ogunsola FT, Anorlu RI, Okoromah CN, Konig B. 
2016. 
High group B streptococcus carriage rates in pregnant women in a tertiary institution in Nigeria. Pan Afr Med J
25:249. doi:10.11604/pamj.2016.25.249.9433.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.11604/pamj.2016.25.249.9433</ArticleId>
            <ArticleId IdType="pmc">PMC5337299</ArticleId>
            <ArticleId IdType="pubmed">28293365</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Foster-Nyarko E, Kwambana B, Aderonke O, Ceesay F, Jarju S, Bojang A, McLellan J, Jafali J, Kampmann B, Ota MO, Adetifa I, Antonio M. 
2016. 
Associations between nasopharyngeal carriage of group B Streptococcus and other respiratory pathogens during early infancy. BMC Microbiol
16:97. doi:10.1186/s12866-016-0714-7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s12866-016-0714-7</ArticleId>
            <ArticleId IdType="pmc">PMC4882866</ArticleId>
            <ArticleId IdType="pubmed">27230066</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Seale AC, Koech AC, Sheppard AE, Barsosio HC, Langat J, Anyango E, Mwakio S, Mwarumba S, Morpeth SC, Anampiu K, Vaughan A, Giess A, Mogeni P, Walusuna L, Mwangudzah H, Mwanzui D, Salim M, Kemp B, Jones C, Mturi N, Tsofa B, Mumbo E, Mulewa D, Bandika V, Soita M, Owiti M, Onzere N, Walker AS, Schrag SJ, Kennedy SH, Fegan G, Crook DW, Berkley JA. 
2016. 
Maternal colonization with Streptococcus agalactiae and associated stillbirth and neonatal disease in coastal Kenya. Nat Microbiol
1:16067. doi:10.1038/nmicrobiol.2016.67.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nmicrobiol.2016.67</ArticleId>
            <ArticleId IdType="pmc">PMC4936517</ArticleId>
            <ArticleId IdType="pubmed">27572968</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Romain AS, Cohen R, Plainvert C, Joubrel C, Bechet S, Perret A, Tazi A, Poyart C, Levy C. 
2018. 
Clinical and laboratory features of group B Streptococcus meningitis in infants and newborns: study of 848 cases in France from 2001–2014. Clin Infect Dis
66:857–864. doi:10.1093/cid/cix896.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/cid/cix896</ArticleId>
            <ArticleId IdType="pubmed">29045606</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bjornsdottir ES, Martins ER, Erlendsdottir H, Haraldsson G, Melo-Cristino J, Kristinsson KG, Ramirez M. 
2016. 
Changing epidemiology of group B streptococcal infections among adults in Iceland: 1975–2014. Clin Microbiol Infect
22:379.e9–379.e16. doi:10.1016/j.cmi.2015.11.020.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cmi.2015.11.020</ArticleId>
            <ArticleId IdType="pubmed">26691681</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Teatero S, Ferrieri P, Martin I, Demczuk W, McGeer A, Fittipaldi N. 
2017. 
Serotype distribution, population structure, and antimicrobial resistance of group B Streptococcus strains recovered from colonized pregnant women. J Clin Microbiol
55:412–422. doi:10.1128/JCM.01615-16.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/JCM.01615-16</ArticleId>
            <ArticleId IdType="pmc">PMC5277510</ArticleId>
            <ArticleId IdType="pubmed">27852675</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Teatero S, McGeer A, Li A, Gomes J, Seah C, Demczuk W, Martin I, Wasserscheid J, Dewar K, Melano RG, Fittipaldi N. 
2015. 
Population structure and antimicrobial resistance of invasive serotype IV group B Streptococcus, Toronto, Ontario, Canada. Emerg Infect Dis
21:585–591. doi:10.3201/eid2014.140759.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3201/eid2014.140759</ArticleId>
            <ArticleId IdType="pmc">PMC4378482</ArticleId>
            <ArticleId IdType="pubmed">25811284</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ferrieri P, Lynfield R, Creti R, Flores AE. 
2013. 
Serotype IV and invasive group B Streptococcus disease in neonates, Minnesota, USA, 2000–2010. Emerg Infect Dis
19:551–558. doi:10.3201/eid1904.121572.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3201/eid1904.121572</ArticleId>
            <ArticleId IdType="pmc">PMC3647718</ArticleId>
            <ArticleId IdType="pubmed">23628320</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bellais S, Six A, Fouet A, Longo M, Dmytruk N, Glaser P, Trieu-Cuot P, Poyart C. 
2012. 
Capsular switching in group B Streptococcus CC17 hypervirulent clone: a future challenge for polysaccharide vaccine development. J Infect Dis
206:1745–1752. doi:10.1093/infdis/jis605.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/infdis/jis605</ArticleId>
            <ArticleId IdType="pubmed">23002446</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Blumberg HM, Stephens DS, Modansky M, Erwin M, Elliot J, Facklam RR, Schuchat A, Baughman W, Farley MM. 
1996. 
Invasive group B streptococcal disease: the emergence of serotype V. J Infect Dis
173:365–373. doi:10.1093/infdis/173.2.365.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/infdis/173.2.365</ArticleId>
            <ArticleId IdType="pubmed">8568297</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Belard S, Toepfner N, Capan-Melser M, Mombo-Ngoma G, Zoleko-Manego R, Groger M, Matsiegui PB, Agnandji ST, Adegnika AA, Gonzalez R, Kremsner PG, Menendez C, Ramharter M, Berner R. 
2015. 
Streptococcus agalactiae serotype distribution and antimicrobial susceptibility in pregnant women in Gabon, Central Africa. Sci Rep
5:17281. doi:10.1038/srep17281.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/srep17281</ArticleId>
            <ArticleId IdType="pmc">PMC4658565</ArticleId>
            <ArticleId IdType="pubmed">26603208</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Suara RO, Adegbola RA, Baker CJ, Secka O, Mulholland EK, Greenwood BM. 
1994. 
Carriage of group B streptococci in pregnant Gambian mothers and their infants. J Infect Dis
170:1316–1319. doi:10.1093/infdis/170.5.1316.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/infdis/170.5.1316</ArticleId>
            <ArticleId IdType="pubmed">7963736</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shabayek S, Abdalla S, Abouzeid AM. 
2014. 
Serotype and surface protein gene distribution of colonizing group B streptococcus in women in Egypt. Epidemiol Infect
142:208–210. doi:10.1017/S0950268813000848.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1017/S0950268813000848</ArticleId>
            <ArticleId IdType="pubmed">23561305</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lachenauer CS, Kasper DL, Shimada J, Ichiman Y, Ohtsuka H, Kaku M, Paoletti LC, Ferrieri P, Madoff LC. 
1999. 
Serotypes VI and VIII predominate among group B streptococci isolated from pregnant Japanese women. J Infect Dis
179:1030–1033. doi:10.1086/314666.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1086/314666</ArticleId>
            <ArticleId IdType="pubmed">10068604</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Suhaimi MES, Desa MNM, Eskandarian N, Pillay SG, Ismail Z, Neela VK, Masri SN, Nordin SA. 
2017. 
Characterization of a group B Streptococcus infection based on the demographics, serotypes, antimicrobial susceptibility and genotypes of selected isolates from sterile and non-sterile isolation sites in three major hospitals in Malaysia. J Infect Public Health
10:14–21. doi:10.1016/j.jiph.2016.01.009.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jiph.2016.01.009</ArticleId>
            <ArticleId IdType="pubmed">27095302</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Slotved HC, Dayie N, Banini JAN, Frimodt-Moller N. 
2017. 
Carriage and serotype distribution of Streptococcus agalactiae in third trimester pregnancy in southern Ghana. BMC Pregnancy Childbirth
17:238. doi:10.1186/s12884-017-1419-0.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s12884-017-1419-0</ArticleId>
            <ArticleId IdType="pmc">PMC5520380</ArticleId>
            <ArticleId IdType="pubmed">28732495</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Karunakaran R, Raja NS, Hafeez A, Puthucheary SD. 
2009. 
Group B Streptococcus infection: epidemiology, serotypes, and antimicrobial susceptibility of selected isolates in the population beyond infancy (excluding females with genital tract- and pregnancy-related isolates) at the University Malaya Medical Centre, Kuala Lumpur. Jpn J Infect Dis
62:192–194.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19468178</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chaudhary M, Rench MA, Baker CJ, Singh P, Hans C, Edwards MS. 
2017. 
Group B streptococcal colonization among pregnant women in Delhi, India. Pediatr Infect Dis J
36:665–669. doi:10.1097/INF.0000000000001514.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/INF.0000000000001514</ArticleId>
            <ArticleId IdType="pubmed">28027278</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Islam MS, Saha SK, Islam M, Modak JK, Shah R, Talukder RR, El Arifeen S, Baqui AH, Darmstadt GL, Mullany LC. 
2016. 
Prevalence, serotype distribution and mortality risk associated with group B Streptococcus colonization of newborns in rural Bangladesh. Pediatr Infect Dis J
35:1309–1312. doi:10.1097/INF.0000000000001306.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/INF.0000000000001306</ArticleId>
            <ArticleId IdType="pubmed">27455441</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ekelund K, Slotved HC, Nielsen HU, Kaltoft MS, Konradsen HB. 
2003. 
Emergence of invasive serotype VIII group B streptococcal infections in Denmark. J Clin Microbiol
41:4442–4444. doi:10.1128/JCM.41.9.4442-4444.2003.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/JCM.41.9.4442-4444.2003</ArticleId>
            <ArticleId IdType="pmc">PMC193804</ArticleId>
            <ArticleId IdType="pubmed">12958288</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Paoletti LJ, Bradford J, Paoletti LC. 
1999. 
A serotype VIII strain among colonizing group B streptococcal isolates in Boston, Massachusetts. J Clin Microbiol
37:3759–3760.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC85754</ArticleId>
            <ArticleId IdType="pubmed">10523595</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yan Y, Hu H, Lu T, Fan H, Hu Y, Li G, Zhang X, Shi Y, Xia R. 
2016. 
Investigation of serotype distribution and resistance genes profile in group B Streptococcus isolated from pregnant women: a Chinese multicenter cohort study. APMIS
124:794–799. doi:10.1111/apm.12570.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/apm.12570</ArticleId>
            <ArticleId IdType="pubmed">27452669</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Toyofuku M, Morozumi M, Hida M, Satoh Y, Sakata H, Shiro H, Ubukata K, Murata M, Iwata S. 
2017. 
Effects of intrapartum antibiotic prophylaxis on neonatal acquisition of group B streptococci. J Pediatr
190:169.e1–173.e1. doi:10.1016/j.jpeds.2017.07.039.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jpeds.2017.07.039</ArticleId>
            <ArticleId IdType="pubmed">29144242</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gudjonsdottir MJ, Hentz E, Berg S, Backhaus E, Elfvin A, Kawash S, Trollfors B. 
2015. 
Serotypes of group B streptococci in western Sweden and comparison with serotypes in two previous studies starting from 1988. BMC Infect Dis
15:507. doi:10.1186/s12879-015-1266-4.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s12879-015-1266-4</ArticleId>
            <ArticleId IdType="pmc">PMC4640215</ArticleId>
            <ArticleId IdType="pubmed">26553333</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Takahara T, Matsubara K, Maihara T, Yamagami Y, Chang B. 
2015. 
Ultra-late-onset meningitis caused by serotype IX group B Streptococcus. Pediatr Infect Dis J
34:801. doi:10.1097/INF.0000000000000732.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/INF.0000000000000732</ArticleId>
            <ArticleId IdType="pubmed">26065666</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Creti R, Imperi M, Pataracchia M, Alfarone G, Recchia S, Baldassarri L. 
2012. 
Identification and molecular characterization of a S. agalactiae strain lacking the capsular locus. Eur J Clin Microbiol Infect Dis
31:233–235. doi:10.1007/s10096-011-1298-7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s10096-011-1298-7</ArticleId>
            <ArticleId IdType="pubmed">21614482</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rosini R, Campisi E, De Chiara M, Tettelin H, Rinaudo D, Toniolo C, Metruccio M, Guidotti S, Sorensen UB, Kilian M, Ramirez M, Janulczyk R, Donati C, Grandi G, Margarit I. 
2015. 
Genomic analysis reveals the molecular basis for capsule loss in the group B Streptococcus population. PLoS One
10:e0125985. doi:10.1371/journal.pone.0125985.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0125985</ArticleId>
            <ArticleId IdType="pmc">PMC4422693</ArticleId>
            <ArticleId IdType="pubmed">25946017</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ramaswamy SV, Ferrieri P, Flores AE, Paoletti LC. 
2006. 
Molecular characterization of nontypeable group B streptococcus. J Clin Microbiol
44:2398–2403. doi:10.1128/JCM.02236-05.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/JCM.02236-05</ArticleId>
            <ArticleId IdType="pmc">PMC1489475</ArticleId>
            <ArticleId IdType="pubmed">16825355</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cieslewicz MJ, Chaffin D, Glusman G, Kasper D, Madan A, Rodrigues S, Fahey J, Wessels MR, Rubens CE. 
2005. 
Structural and genetic diversity of group B streptococcus capsular polysaccharides. Infect Immun
73:3096–3103. doi:10.1128/IAI.73.5.3096-3103.2005.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/IAI.73.5.3096-3103.2005</ArticleId>
            <ArticleId IdType="pmc">PMC1087335</ArticleId>
            <ArticleId IdType="pubmed">15845517</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Martins ER, Melo-Cristino J, Ramirez M. 
2007. 
Reevaluating the serotype II capsular locus of Streptococcus agalactiae. J Clin Microbiol
45:3384–3386. doi:10.1128/JCM.01296-07.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/JCM.01296-07</ArticleId>
            <ArticleId IdType="pmc">PMC2045322</ArticleId>
            <ArticleId IdType="pubmed">17715372</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Martins ER, Melo-Cristino J, Ramirez M. 
2010. 
Evidence for rare capsular switching in Streptococcus agalactiae. J Bacteriol
192:1361–1369. doi:10.1128/JB.01130-09.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/JB.01130-09</ArticleId>
            <ArticleId IdType="pmc">PMC2820851</ArticleId>
            <ArticleId IdType="pubmed">20023016</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Meehan M, Cunney R, Cafferkey M. 
2014. 
Molecular epidemiology of group B streptococci in Ireland reveals a diverse population with evidence of capsular switching. Eur J Clin Microbiol Infect Dis
33:1155–1162. doi:10.1007/s10096-014-2055-5.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s10096-014-2055-5</ArticleId>
            <ArticleId IdType="pubmed">24469423</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Neemuchwala A, Teatero S, Athey TB, McGeer A, Fittipaldi N. 
2016. 
Capsular switching and other large-scale recombination events in invasive sequence type 1 group B Streptococcus. Emerg Infect Dis
22:1941–1944. doi:10.3201//eid2211.152064.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3201//eid2211.152064</ArticleId>
            <ArticleId IdType="pmc">PMC5088006</ArticleId>
            <ArticleId IdType="pubmed">27767925</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nesin M, Ramirez M, Tomasz A. 
1998. 
Capsular transformation of a multidrug-resistant Streptococcus pneumoniae in vivo. J Infect Dis
177:707–713. doi:10.1086/514242.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1086/514242</ArticleId>
            <ArticleId IdType="pubmed">9498451</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ramirez M, Tomasz A. 
1999. 
Acquisition of new capsular genes among clinical isolates of antibiotic-resistant Streptococcus pneumoniae. Microb Drug Resist
5:241–246. doi:10.1089/mdr.1999.5.241.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1089/mdr.1999.5.241</ArticleId>
            <ArticleId IdType="pubmed">10647080</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Stålhammar-Carlemalm M, Stenberg L, Lindahl G. 
1993. 
Protein rib: a novel group B streptococcal cell surface protein that confers protective immunity and is expressed by most strains causing invasive infections. J Exp Med
177:1593–1603. doi:10.1084/jem.177.6.1593.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1084/jem.177.6.1593</ArticleId>
            <ArticleId IdType="pmc">PMC2191029</ArticleId>
            <ArticleId IdType="pubmed">8496678</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bevanger L, Naess AI. 
1985. 
Mouse-protective antibodies against the Ibc proteins of group B streptococci. Acta Pathol Microbiol Immunol Scand B
93:121–124.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">3893032</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wessels MR, Rubens CE, Benedi VJ, Kasper DL. 
1989. 
Definition of a bacterial virulence factor: sialylation of the group B streptococcal capsule. Proc Natl Acad Sci U S A
86:8983–8987.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC298416</ArticleId>
            <ArticleId IdType="pubmed">2554337</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lindahl G, Stalhammar-Carlemalm M, Areschoug T. 
2005. 
Surface proteins of Streptococcus agalactiae and related proteins in other bacterial pathogens. Clin Microbiol Rev
18:102–127. doi:10.1128/CMR.18.1.102-127.2005.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/CMR.18.1.102-127.2005</ArticleId>
            <ArticleId IdType="pmc">PMC544178</ArticleId>
            <ArticleId IdType="pubmed">15653821</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ferrieri P, Flores AE. 
1997. 
Surface protein expression in group B streptococcal invasive isolates. Adv Exp Med Biol
418:635–637. doi:10.1007/978-1-4899-1825-3_148.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/978-1-4899-1825-3_148</ArticleId>
            <ArticleId IdType="pubmed">9331732</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gabrielsen C, Mæland JA, Lyng RV, Radtke A, Afset JE. 
2017. 
Molecular characteristics of Streptococcus agalactiae strains deficient in alpha-like protein encoding genes. J Med Microbiol
66:26–33. doi:10.1099/jmm.0.000412.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1099/jmm.0.000412</ArticleId>
            <ArticleId IdType="pubmed">28032541</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Smith TC, Roehl SA, Pillai P, Li S, Marrs CF, Foxman B. 
2007. 
Distribution of novel and previously investigated virulence genes in colonizing and invasive isolates of Streptococcus agalactiae. Epidemiol Infect
135:1046–1054. doi:10.1017/S0950268806007515.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1017/S0950268806007515</ArticleId>
            <ArticleId IdType="pmc">PMC2870641</ArticleId>
            <ArticleId IdType="pubmed">17156495</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tenover FC, Arbeit RD, Goering RV, Mickelsen PA, Murray BE, Persing DH, Swaminathan B. 
1995. 
Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol
33:2233–2239.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC228385</ArticleId>
            <ArticleId IdType="pubmed">7494007</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fasola E, Livdahl C, Ferrieri P. 
1993. 
Molecular analysis of multiple isolates of the major serotypes of group B streptococci. J Clin Microbiol
31:2616–2620.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC265946</ArticleId>
            <ArticleId IdType="pubmed">8253957</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Benson JA, Ferrieri P. 
2001. 
Rapid pulsed-field gel electrophoresis method for group B Streptococcus isolates. J Clin Microbiol
39:3006–3008. doi:10.1128/JCM.39.8.3006-3008.2001.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/JCM.39.8.3006-3008.2001</ArticleId>
            <ArticleId IdType="pmc">PMC88282</ArticleId>
            <ArticleId IdType="pubmed">11474035</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Skjaervold NK, Bergh K, Bevanger L. 
2004. 
Distribution of PFGE types of invasive Norwegian group B streptococci in relation to serotypes. Indian J Med Res
119(Suppl):201–204.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15232195</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Souza VC, Kegele FC, Souza SR, Neves FP, de Paula GR, Barros RR. 
2013. 
Antimicrobial susceptibility and genetic diversity of Streptococcus agalactiae recovered from newborns and pregnant women in Brazil. Scand J Infect Dis
45:780–785. doi:10.3109/00365548.2013.810814.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3109/00365548.2013.810814</ArticleId>
            <ArticleId IdType="pubmed">23876189</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Diedrick MJ, Flores AE, Hillier SL, Creti R, Ferrieri P. 
2010. 
Clonal analysis of colonizing group B Streptococcus, serotype IV, an emerging pathogen in the United States. J Clin Microbiol
48:3100–3104. doi:10.1128/JCM.00277-10.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/JCM.00277-10</ArticleId>
            <ArticleId IdType="pmc">PMC2937746</ArticleId>
            <ArticleId IdType="pubmed">20610684</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ellis S, Kotiw M, Garland SM. 
1996. 
Restriction endonuclease analysis of group B streptococcal isolates from two distinct geographical regions. J Hosp Infect
33:279–287. doi:10.1016/S0195-6701(96)90014-6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0195-6701(96)90014-6</ArticleId>
            <ArticleId IdType="pubmed">8864940</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jones N, Bohnsack JF, Takahashi S, Oliver KA, Chan MS, Kunst F, Glaser P, Rusniok C, Crook DW, Harding RM, Bisharat N, Spratt BG. 
2003. 
Multilocus sequence typing system for group B streptococcus. J Clin Microbiol
41:2530–2536. doi:10.1128/JCM.41.6.2530-2536.2003.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/JCM.41.6.2530-2536.2003</ArticleId>
            <ArticleId IdType="pmc">PMC156480</ArticleId>
            <ArticleId IdType="pubmed">12791877</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jolley KA, Chan MS, Maiden MC. 
2004. 
mlstdbNet—distributed multi-locus sequence typing (MLST) databases. BMC Bioinformatics
5:86. doi:10.1186/1471-2105-5-86.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/1471-2105-5-86</ArticleId>
            <ArticleId IdType="pmc">PMC459212</ArticleId>
            <ArticleId IdType="pubmed">15230973</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kang HM, Lee HJ, Lee H, Jo DS, Lee HS, Kim TS, Shin JH, Yun KW, Lee B, Choi EH. 
2017. 
Genotype characterization of group B Streptococcus isolated from infants with invasive diseases in South Korea. Pediatr Infect Dis J
36:e242–e247. doi:10.1097/INF.0000000000001531.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/INF.0000000000001531</ArticleId>
            <ArticleId IdType="pubmed">28060047</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lo CW, Liu HC, Lee CC, Lin CL, Chen CL, Jeng MJ, Chiu CH. 
2017. 
Serotype distribution and clinical correlation of Streptococcus agalactiae causing invasive disease in infants and children in Taiwan. J Microbiol Immunol Infect
2017:S1684-1182(17)30228-1. doi:10.1016/j.jmii.2017.09.002.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jmii.2017.09.002</ArticleId>
            <ArticleId IdType="pubmed">29100794</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sorensen UB, Poulsen K, Ghezzo C, Margarit I, Kilian M. 
2010. 
Emergence and global dissemination of host-specific Streptococcus agalactiae clones. mBio
1:e00178-10. doi:10.1128/mBio.00178-10.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/mBio.00178-10</ArticleId>
            <ArticleId IdType="pmc">PMC2932510</ArticleId>
            <ArticleId IdType="pubmed">20824105</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bisharat N, Jones N, Marchaim D, Block C, Harding RM, Yagupsky P, Peto T, Crook DW. 
2005. 
Population structure of group B streptococcus from a low-incidence region for invasive neonatal disease. Microbiology
151:1875–1881. doi:10.1099/mic.0.27826-0.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1099/mic.0.27826-0</ArticleId>
            <ArticleId IdType="pubmed">15941995</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jones N, Oliver KA, Barry J, Harding RM, Bisharat N, Spratt BG, Peto T, Crook DW. 
2006. 
Enhanced invasiveness of bovine-derived neonatal sequence type 17 group B streptococcus is independent of capsular serotype. Clin Infect Dis
42:915–924. doi:10.1086/500324.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1086/500324</ArticleId>
            <ArticleId IdType="pubmed">16511753</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Luan SL, Granlund M, Sellin M, Lagergard T, Spratt BG, Norgren M. 
2005. 
Multilocus sequence typing of Swedish invasive group B streptococcus isolates indicates a neonatally associated genetic lineage and capsule switching. J Clin Microbiol
43:3727–3733. doi:10.1128/JCM.43.8.3727-3733.2005.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/JCM.43.8.3727-3733.2005</ArticleId>
            <ArticleId IdType="pmc">PMC1233917</ArticleId>
            <ArticleId IdType="pubmed">16081902</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Martins ER, Pessanha MA, Ramirez M, Melo-Cristino J. 
2007. 
Analysis of group B streptococcal isolates from infants and pregnant women in Portugal revealing two lineages with enhanced invasiveness. J Clin Microbiol
45:3224–3229. doi:10.1128/JCM.01182-07.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/JCM.01182-07</ArticleId>
            <ArticleId IdType="pmc">PMC2045366</ArticleId>
            <ArticleId IdType="pubmed">17699641</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lin FY, Whiting A, Adderson E, Takahashi S, Dunn DM, Weiss R, Azimi PH, Philips JB III, Weisman LE, Regan J, Clark P, Rhoads GG, Frasch CE, Troendle J, Moyer P, Bohnsack JF. 
2006. 
Phylogenetic lineages of invasive and colonizing strains of serotype III group B streptococci from neonates: a multicenter prospective study. J Clin Microbiol
44:1257–1261. doi:10.1128/JCM.44.4.1257-1261.2006.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/JCM.44.4.1257-1261.2006</ArticleId>
            <ArticleId IdType="pmc">PMC1448625</ArticleId>
            <ArticleId IdType="pubmed">16597848</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Manning SD, Springman AC, Lehotzky E, Lewis MA, Whittam TS, Davies HD. 
2009. 
Multilocus sequence types associated with neonatal group B streptococcal sepsis and meningitis in Canada. J Clin Microbiol
47:1143–1148. doi:10.1128/JCM.01424-08.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/JCM.01424-08</ArticleId>
            <ArticleId IdType="pmc">PMC2668308</ArticleId>
            <ArticleId IdType="pubmed">19158264</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Limansky AS, Guardati MC, Sutich EG, Toresani IE, Bogado IE, Joannas GM, Viale AM. 
1995. 
Characterization of clinical isolates of Streptococcus agalactiae by random amplified polymorphic DNA using degenerate oligonucleotides. Medicina (B Aires)
55:681–684.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8731579</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Martinez G, Harel J, Higgins R, Lacouture S, Daignault D, Gottschalk M. 
2000. 
Characterization of Streptococcus agalactiae isolates of bovine and human origin by randomly amplified polymorphic DNA analysis. J Clin Microbiol
38:71–78.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC86023</ArticleId>
            <ArticleId IdType="pubmed">10618066</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chatellier S, Ramanantsoa C, Harriau P, Rolland K, Rosenau A, Quentin R. 
1997. 
Characterization of Streptococcus agalactiae strains by randomly amplified polymorphic DNA analysis. J Clin Microbiol
35:2573–2579.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC230013</ArticleId>
            <ArticleId IdType="pubmed">9316910</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Brzychczy-Wloch M, Gosiewski T, Bodaszewska M, Pabian W, Bulanda M, Kochan P, Strus M, Heczko PB. 
2010. 
Genetic characterization and diversity of Streptococcus agalactiae isolates with macrolide resistance. J Med Microbiol
59:780–786. doi:10.1099/jmm.0.018176-0.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1099/jmm.0.018176-0</ArticleId>
            <ArticleId IdType="pubmed">20339021</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Brandolini M, Corbella M, Cambieri P, Barbarini D, Sassera D, Stronati M, Marone P. 
2014. 
Late-onset neonatal group B streptococcal disease associated with breast milk transmission: molecular typing using RAPD-PCR. Early Hum Dev
90(Suppl 1):S84–S86. doi:10.1016/S0378-3782(14)70025-8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0378-3782(14)70025-8</ArticleId>
            <ArticleId IdType="pubmed">24709469</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Toresani I, Limansky A, Bogado I, Guardati MC, Viale A, Sutich EG. 
2001. 
Phenotypic and genotypic study of Streptococcus agalactiae in vagina of pregnant women in Argentina. Medicina (B Aires)
61:295–300.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11474877</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>El Aila NA, Tency I, Claeys G, Saerens B, De Backer E, Temmerman M, Verhelst R, Vaneechoutte M. 
2009. 
Genotyping of Streptococcus agalactiae (group B streptococci) isolated from vaginal and rectal swabs of women at 35–37 weeks of pregnancy. BMC Infect Dis
9:153. doi:10.1186/1471-2334-9-153.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/1471-2334-9-153</ArticleId>
            <ArticleId IdType="pmc">PMC2753344</ArticleId>
            <ArticleId IdType="pubmed">19747377</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Brzychczy-Wloch M, Strus M, Pawlik D, Gosiewski T, Krzysztof R, Drzewiecki A, Lauterbach R, Heczko PB. 
2008. 
Studies on the possible application of molecular methods in diagnosing carriers and in similarity analysis of group B streptococci (Streptococcus agalactiae). Med Dosw Mikrobiol
60:91–99.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18819445</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Strus M, Pawlik D, Brzychczy-Włoch M, Gosiewski T, Rytlewski K, Lauterbach R, Heczko PB. 
2009. 
Group B streptococcus colonization of pregnant women and their children observed on obstetric and neonatal wards of the University Hospital in Krakow, Poland. J Med Microbiol
58:228–233. doi:10.1099/jmm.0.002865-0.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1099/jmm.0.002865-0</ArticleId>
            <ArticleId IdType="pubmed">19141741</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hannoun A, Shehab M, Khairallah MT, Sabra A, Abi-Rached R, Bazi T, Yunis KA, Araj GF, Matar GM. 
2009. 
Correlation between group B streptococcal genotypes, their antimicrobial resistance profiles, and virulence genes among pregnant women in Lebanon. Int J Microbiol
2009:796512. doi:10.1155/2009/796512.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1155/2009/796512</ArticleId>
            <ArticleId IdType="pmc">PMC2817894</ArticleId>
            <ArticleId IdType="pubmed">20148175</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Muller AE, Valkenburg-van den Berg AW, Kreft D, Oostvogel PM, Sprij AJ, van Belkum A. 
2008. 
Low rate of carriage of macrolide-resistant group B streptococci in pregnant women in The Netherlands. Eur J Obstet Gynecol Reprod Biol
137:17–20. doi:10.1016/j.ejogrb.2007.04.001.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ejogrb.2007.04.001</ArticleId>
            <ArticleId IdType="pubmed">17482748</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang GW, Kotiw M, Daggard G. 
2002. 
A RAPD-PCR genotyping assay which correlates with serotypes of group B streptococci. Lett Appl Microbiol
35:247–250. doi:10.1046/j.1472-765X.2002.01177.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1046/j.1472-765X.2002.01177.x</ArticleId>
            <ArticleId IdType="pubmed">12180950</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Al Nakib M, Longo M, Tazi A, Billoet A, Raymond J, Trieu-Cuot P, Poyart C. 
2011. 
Comparison of the Diversilab(R) system with multi-locus sequence typing and pulsed-field gel electrophoresis for the characterization of Streptococcus agalactiae invasive strains. J Microbiol Methods
85:137–142. doi:10.1016/j.mimet.2011.02.010.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.mimet.2011.02.010</ArticleId>
            <ArticleId IdType="pubmed">21338630</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Amal MN, Zamri-Saad M, Siti-Zahrah A, Zulkafli AR, Nur-Nazifah M. 
2013. 
Molecular characterization of Streptococcus agalactiae strains isolated from fishes in Malaysia. J Appl Microbiol
115:20–29. doi:10.1111/jam.12210.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/jam.12210</ArticleId>
            <ArticleId IdType="pubmed">23557382</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tyler KD, Wang G, Tyler SD, Johnson WM. 
1997. 
Factors affecting reliability and reproducibility of amplification-based DNA fingerprinting of representative bacterial pathogens. J Clin Microbiol
35:339–346.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC229576</ArticleId>
            <ArticleId IdType="pubmed">9003592</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Deplano A, Schuermans A, Van Eldere J, Witte W, Meugnier H, Etienne J, Grundmann H, Jonas D, Noordhoek GT, Dijkstra J, van Belkum A, van Leeuwen W, Tassios PT, Legakis NJ, van der Zee A, Bergmans A, Blanc DS, Tenover FC, Cookson BC, O'Neil G, Struelens MJ. 
2000. 
Multicenter evaluation of epidemiological typing of methicillin-resistant Staphylococcus aureus strains by repetitive-element PCR analysis. The European Study Group on Epidemiological Markers of the ESCMID. J Clin Microbiol
38:3527–3533.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC87431</ArticleId>
            <ArticleId IdType="pubmed">11015358</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yazdankhah SP, Lindstedt BA. 
2007. 
Variable number tandem repeat typing of bacteria. Methods Mol Biol
396:395–405. doi:10.1007/978-1-59745-515-2_25.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/978-1-59745-515-2_25</ArticleId>
            <ArticleId IdType="pubmed">18025706</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Radtke A, Lindstedt BA, Afset JE, Bergh K. 
2010. 
Rapid multiple-locus variant-repeat assay (MLVA) for genotyping of Streptococcus agalactiae. J Clin Microbiol
48:2502–2508. doi:10.1128/JCM.00234-10.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/JCM.00234-10</ArticleId>
            <ArticleId IdType="pmc">PMC2897478</ArticleId>
            <ArticleId IdType="pubmed">20504982</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dmitriev AV, Shen AD, Totolian AA. 
2007. 
Streptococcus agalactiae sak0192 gene contains direct repeats and spacers that are genetic markers for characterizing the strains. Mol Gen Mikrobiol Virusol
2007:37–42.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18154080</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lamy MC, Dramsi S, Billoet A, Reglier-Poupet H, Tazi A, Raymond J, Guerin F, Couve E, Kunst F, Glaser P, Trieu-Cuot P, Poyart C. 
2006. 
Rapid detection of the “highly virulent” group B Streptococcus ST-17 clone. Microbes Infect
8:1714–1722. doi:10.1016/j.micinf.2006.02.008.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.micinf.2006.02.008</ArticleId>
            <ArticleId IdType="pubmed">16822689</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Reinscheid DJ, Gottschalk B, Schubert A, Eikmanns BJ, Chhatwal GS. 
2001. 
Identification and molecular analysis of PcsB, a protein required for cell wall separation of group B streptococcus. J Bacteriol
183:1175–1183. doi:10.1128/JB.183.4.1175-1183.2001.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/JB.183.4.1175-1183.2001</ArticleId>
            <ArticleId IdType="pmc">PMC94990</ArticleId>
            <ArticleId IdType="pubmed">11157929</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rosenau A, Martins K, Amor S, Gannier F, Lanotte P, van der Mee-Marquet N, Mereghetti L, Quentin R. 
2007. 
Evaluation of the ability of Streptococcus agalactiae strains isolated from genital and neonatal specimens to bind to human fibrinogen and correlation with characteristics of the fbsA and fbsB genes. Infect Immun
75:1310–1317. doi:10.1128/IAI.00996-06.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/IAI.00996-06</ArticleId>
            <ArticleId IdType="pmc">PMC1828567</ArticleId>
            <ArticleId IdType="pubmed">17158903</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Haguenoer E, Baty G, Pourcel C, Lartigue MF, Domelier AS, Rosenau A, Quentin R, Mereghetti L, Lanotte P. 
2011. 
A multi locus variable number of tandem repeat analysis (MLVA) scheme for Streptococcus agalactiae genotyping. BMC Microbiol
11:171. doi:10.1186/1471-2180-11-171.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/1471-2180-11-171</ArticleId>
            <ArticleId IdType="pmc">PMC3163538</ArticleId>
            <ArticleId IdType="pubmed">21794143</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Otaguiri ES, Morguette AE, Tavares ER, dos Santos PM, Morey AT, Cardoso JD, Perugini MR, Yamauchi LM, Yamada-Ogatta SF. 
2013. 
Commensal Streptococcus agalactiae isolated from patients seen at University Hospital of Londrina, Parana, Brazil: capsular types, genotyping, antimicrobial susceptibility and virulence determinants. BMC Microbiol
13:297. doi:10.1186/1471-2180-13-297.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/1471-2180-13-297</ArticleId>
            <ArticleId IdType="pmc">PMC3878097</ArticleId>
            <ArticleId IdType="pubmed">24359590</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Beigverdi R, Jabalameli F, Mirsalehian A, Hantoushzadeh S, Boroumandi S, Taherikalani M, Emaneini M. 
2014. 
Virulence factors, antimicrobial susceptibility and molecular characterization of Streptococcus agalactiae isolated from pregnant women. Acta Microbiol Immunol Hung
61:425–434. doi:10.1556/AMicr.61.2014.4.4.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1556/AMicr.61.2014.4.4</ArticleId>
            <ArticleId IdType="pubmed">25496971</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Barrangou R, Horvath P. 
2012. 
CRISPR: new horizons in phage resistance and strain identification. Annu Rev Food Sci Technol
3:143–162. doi:10.1146/annurev-food-022811-101134.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1146/annurev-food-022811-101134</ArticleId>
            <ArticleId IdType="pubmed">22224556</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shariat N, Dudley EG. 
2014. 
CRISPRs: molecular signatures used for pathogen subtyping. Appl Environ Microbiol
80:430–439. doi:10.1128/AEM.02790-13.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/AEM.02790-13</ArticleId>
            <ArticleId IdType="pmc">PMC3911090</ArticleId>
            <ArticleId IdType="pubmed">24162568</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lopez-Sanchez MJ, Sauvage E, Da Cunha V, Clermont D, Ratsima Hariniaina E, Gonzalez-Zorn B, Poyart C, Rosinski-Chupin I, Glaser P. 
2012. 
The highly dynamic CRISPR1 system of Streptococcus agalactiae controls the diversity of its mobilome. Mol Microbiol
85:1057–1071. doi:10.1111/j.1365-2958.2012.08172.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1365-2958.2012.08172.x</ArticleId>
            <ArticleId IdType="pubmed">22834929</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Makarova KS, Wolf YI, Alkhnbashi OS, Costa F, Shah SA, Saunders SJ, Barrangou R, Brouns SJ, Charpentier E, Haft DH, Horvath P, Moineau S, Mojica FJ, Terns RM, Terns MP, White MF, Yakunin AF, Garrett RA, van der Oost J, Backofen R, Koonin EV. 
2015. 
An updated evolutionary classification of CRISPR-Cas systems. Nat Rev Microbiol
13:722–736. doi:10.1038/nrmicro3569.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nrmicro3569</ArticleId>
            <ArticleId IdType="pmc">PMC5426118</ArticleId>
            <ArticleId IdType="pubmed">26411297</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Beauruelle C, Pastuszka A, Horvath P, Perrotin F, Mereghetti L, Lanotte P. 
2017. 
CRISPR: a useful genetic feature to follow vaginal carriage of group B Streptococcus. Front Microbiol
8:1981. doi:10.3389/fmicb.2017.01981.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fmicb.2017.01981</ArticleId>
            <ArticleId IdType="pmc">PMC5641575</ArticleId>
            <ArticleId IdType="pubmed">29075246</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Di Renzo GC, Melin P, Berardi A, Blennow M, Carbonell-Estrany X, Donzelli GP, Hakansson S, Hod M, Hughes R, Kurtzer M, Poyart C, Shinwell E, Stray-Pedersen B, Wielgos M, El Helali N. 
2015. 
Intrapartum GBS screening and antibiotic prophylaxis: a European consensus conference. J Matern Fetal Neonatal Med
28:766–782. doi:10.3109/14767058.2014.934804.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3109/14767058.2014.934804</ArticleId>
            <ArticleId IdType="pubmed">25162923</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Agence Nationale d'Accréditation et d'Evaluation en Santé 
2003. 
Antenatal prevention of early neonatal bacterial infection (September 2001). J Gynecol Obstet Biol Reprod (Paris)
32:68–74.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12592187</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jordan HT, Farley MM, Craig A, Mohle-Boetani J, Harrison LH, Petit S, Lynfield R, Thomas A, Zansky S, Gershman K, Albanese BA, Schaffner W, Schrag SJ. 
2008. 
Revisiting the need for vaccine prevention of late-onset neonatal group B streptococcal disease: a multistate, population-based analysis. Pediatr Infect Dis J
27:1057–1064. doi:10.1097/INF.0b013e318180b3b9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/INF.0b013e318180b3b9</ArticleId>
            <ArticleId IdType="pubmed">18989238</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Seedat F, Stinton C, Patterson J, Geppert J, Tan B, Robinson ER, McCarthy ND, Uthman OA, Freeman K, Johnson SA, Fraser H, Brown CS, Clarke A, Taylor-Phillips S. 
2017. 
Adverse events in women and children who have received intrapartum antibiotic prophylaxis treatment: a systematic review. BMC Pregnancy Childbirth
17:247. doi:10.1186/s12884-017-1432-3.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s12884-017-1432-3</ArticleId>
            <ArticleId IdType="pmc">PMC5530570</ArticleId>
            <ArticleId IdType="pubmed">28747160</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Aloisio I, Mazzola G, Corvaglia LT, Tonti G, Faldella G, Biavati B, Di Gioia D. 
2014. 
Influence of intrapartum antibiotic prophylaxis against group B Streptococcus on the early newborn gut composition and evaluation of the anti-Streptococcus activity of Bifidobacterium strains. Appl Microbiol Biotechnol
98:6051–6060. doi:10.1007/s00253-014-5712-9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00253-014-5712-9</ArticleId>
            <ArticleId IdType="pubmed">24687755</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Aloisio I, Quagliariello A, De Fanti S, Luiselli D, De Filippo C, Albanese D, Corvaglia LT, Faldella G, Di Gioia D. 
2016. 
Evaluation of the effects of intrapartum antibiotic prophylaxis on newborn intestinal microbiota using a sequencing approach targeted to multi hypervariable 16S rDNA regions. Appl Microbiol Biotechnol
100:5537–5546. doi:10.1007/s00253-016-7410-2.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00253-016-7410-2</ArticleId>
            <ArticleId IdType="pubmed">26971496</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Corvaglia L, Tonti G, Martini S, Aceti A, Mazzola G, Aloisio I, Di Gioia D, Faldella G. 
2016. 
Influence of intrapartum antibiotic prophylaxis for group B streptococcus on gut microbiota in the first month of life. J Pediatr Gastroenterol Nutr
62:304–308. doi:10.1097/MPG.0000000000000928.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/MPG.0000000000000928</ArticleId>
            <ArticleId IdType="pubmed">26237371</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jaureguy F, Carton M, Panel P, Foucaud P, Butel MJ, Doucet-Populaire F. 
2004. 
Effects of intrapartum penicillin prophylaxis on intestinal bacterial colonization in infants. J Clin Microbiol
42:5184–5188. doi:10.1128/JCM.42.11.5184-5188.2004.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/JCM.42.11.5184-5188.2004</ArticleId>
            <ArticleId IdType="pmc">PMC525278</ArticleId>
            <ArticleId IdType="pubmed">15528713</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Arboleya S, Sanchez B, Milani C, Duranti S, Solis G, Fernandez N, de los Reyes-Gavilan CG, Ventura M, Margolles A, Gueimonde M. 
2015. 
Intestinal microbiota development in preterm neonates and effect of perinatal antibiotics. J Pediatr
166:538–544. doi:10.1016/j.jpeds.2014.09.041.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jpeds.2014.09.041</ArticleId>
            <ArticleId IdType="pubmed">25444008</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Arboleya S, Sanchez B, Solis G, Fernandez N, Suarez M, Hernandez-Barranco AM, Milani C, Margolles A, de Los Reyes-Gavilan CG, Ventura M, Gueimonde M. 
2016. 
Impact of prematurity and perinatal antibiotics on the developing intestinal microbiota: a functional inference study. Int J Mol Sci
17:E649. doi:10.3390/ijms17050649.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/ijms17050649</ArticleId>
            <ArticleId IdType="pmc">PMC4881475</ArticleId>
            <ArticleId IdType="pubmed">27136545</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mazzola G, Murphy K, Ross RP, Di Gioia D, Biavati B, Corvaglia LT, Faldella G, Stanton C. 
2016. 
Early gut microbiota perturbations following intrapartum antibiotic prophylaxis to prevent group B streptococcal disease. PLoS One
11:e0157527. doi:10.1371/journal.pone.0157527.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0157527</ArticleId>
            <ArticleId IdType="pmc">PMC4917232</ArticleId>
            <ArticleId IdType="pubmed">27332552</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Salter SJ, Cox MJ, Turek EM, Calus ST, Cookson WO, Moffatt MF, Turner P, Parkhill J, Loman NJ, Walker AW. 
2014. 
Reagent and laboratory contamination can critically impact sequence-based microbiome analyses. BMC Biol
12:87. doi:10.1186/s12915-014-0087-z.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s12915-014-0087-z</ArticleId>
            <ArticleId IdType="pmc">PMC4228153</ArticleId>
            <ArticleId IdType="pubmed">25387460</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Palmeira P, Quinello C, Silveira-Lessa AL, Zago CA, Carneiro-Sampaio M. 
2012. 
IgG placental transfer in healthy and pathological pregnancies. Clin Dev Immunol
2012:985646. doi:10.1155/2012/985646.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1155/2012/985646</ArticleId>
            <ArticleId IdType="pmc">PMC3251916</ArticleId>
            <ArticleId IdType="pubmed">22235228</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Baker CJ, Kasper DL. 
1976. 
Correlation of maternal antibody deficiency with susceptibility to neonatal group B streptococcal infection. N Engl J Med
294:753–756. doi:10.1056/NEJM197604012941404.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1056/NEJM197604012941404</ArticleId>
            <ArticleId IdType="pubmed">768760</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Englund JA.
2007. 
The influence of maternal immunization on infant immune responses. J Comp Pathol
137(Suppl 1):S16–S19. doi:10.1016/j.jcpa.2007.04.006.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jcpa.2007.04.006</ArticleId>
            <ArticleId IdType="pubmed">17553516</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Heath PT.
2016. 
Status of vaccine research and development of vaccines for GBS. Vaccine
34:2876–2879. doi:10.1016/j.vaccine.2015.12.072.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.vaccine.2015.12.072</ArticleId>
            <ArticleId IdType="pubmed">26988258</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lin SM, Zhi Y, Ahn KB, Lim S, Seo HS. 
2018. 
Status of group B streptococcal vaccine development. Clin Exp Vaccine Res
7:76–81. doi:10.7774/cevr.2018.7.1.76.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.7774/cevr.2018.7.1.76</ArticleId>
            <ArticleId IdType="pmc">PMC5795048</ArticleId>
            <ArticleId IdType="pubmed">29399583</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Madhi SA, Cutland CL, Jose L, Koen A, Govender N, Wittke F, Olugbosi M, Meulen AS, Baker S, Dull PM, Narasimhan V, Slobod K. 
2016. 
Safety and immunogenicity of an investigational maternal trivalent group B streptococcus vaccine in healthy women and their infants: a randomised phase 1b/2 trial. Lancet Infect Dis
16:923–934. doi:10.1016/S1473-3099(16)00152-3.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S1473-3099(16)00152-3</ArticleId>
            <ArticleId IdType="pubmed">27139805</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Madhi SA, Koen A, Cutland CL, Jose L, Govender N, Wittke F, Olugbosi M, Sobanjo-Ter Meulen A, Baker S, Dull PM, Narasimhan V, Slobod K. 
2017. 
Antibody kinetics and response to routine vaccinations in infants born to women who received an investigational trivalent group B Streptococcus polysaccharide CRM197-conjugate vaccine during pregnancy. Clin Infect Dis
65:1897–1904. doi:10.1093/cid/cix666.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/cid/cix666</ArticleId>
            <ArticleId IdType="pmc">PMC5848233</ArticleId>
            <ArticleId IdType="pubmed">29029127</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Maione D, Margarit I, Rinaudo CD, Masignani V, Mora M, Scarselli M, Tettelin H, Brettoni C, Iacobini ET, Rosini R, D'Agostino N, Miorin L, Buccato S, Mariani M, Galli G, Nogarotto R, Nardi-Dei V, Vegni F, Fraser C, Mancuso G, Teti G, Madoff LC, Paoletti LC, Rappuoli R, Kasper DL, Telford JL, Grandi G. 
2005. 
Identification of a universal group B streptococcus vaccine by multiple genome screen. Science
309:148–150. doi:10.1126/science.1109869.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1126/science.1109869</ArticleId>
            <ArticleId IdType="pmc">PMC1351092</ArticleId>
            <ArticleId IdType="pubmed">15994562</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Larsson C, Lindroth M, Nordin P, Stalhammar-Carlemalm M, Lindahl G, Krantz I. 
2006. 
Association between low concentrations of antibodies to protein alpha and Rib and invasive neonatal group B streptococcal infection. Arch Dis Child Fetal Neonatal Ed
91:F403–F408. doi:10.1136/adc.2005.090472.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/adc.2005.090472</ArticleId>
            <ArticleId IdType="pmc">PMC2672751</ArticleId>
            <ArticleId IdType="pubmed">17056838</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cutland CL, Madhi SA, Zell ER, Kuwanda L, Laque M, Groome M, Gorwitz R, Thigpen MC, Patel R, Velaphi SC, Adrian P, Klugman K, Schuchat A, Schrag SJ. 
2009. 
Chlorhexidine maternal-vaginal and neonate body wipes in sepsis and vertical transmission of pathogenic bacteria in South Africa: a randomised, controlled trial. Lancet
374:1909–1916. doi:10.1016/S0140-6736(09)61339-8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0140-6736(09)61339-8</ArticleId>
            <ArticleId IdType="pubmed">19846212</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kim S-Y, Russell LB, Park J, Verani JR, Madhi SA, Cutland CL, Schrag SJ, Sinha A. 
2014. 
Cost-effectiveness of a potential group B streptococcal vaccine program for pregnant women in South Africa. Vaccine
32:1954–1963. doi:10.1016/j.vaccine.2014.01.062.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.vaccine.2014.01.062</ArticleId>
            <ArticleId IdType="pubmed">24530145</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kim SY, Nguyen C, Russell LB, Tomczyk S, Abdul-Hakeem F, Schrag SJ, Verani JR, Sinha A. 
2017. 
Cost-effectiveness of a potential group B streptococcal vaccine for pregnant women in the United States. Vaccine
35:6238–6247. doi:10.1016/j.vaccine.2017.08.085.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.vaccine.2017.08.085</ArticleId>
            <ArticleId IdType="pubmed">28951085</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Furfaro LL, Chang BJ, Payne MS. 
2018. 
Applications for bacteriophage therapy during pregnancy and the perinatal period. Front Microbiol
8:2660. doi:10.3389/fmicb.2017.02660.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fmicb.2017.02660</ArticleId>
            <ArticleId IdType="pmc">PMC5768649</ArticleId>
            <ArticleId IdType="pubmed">29375525</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
